Stroke. 2006;37:2858-2859
Published online before print September 28, 2006,
doi: 10.1161/01.STR.0000244823.59463.1f
(Stroke. 2006;37:2858.)
© 2006 American Heart Association, Inc.
Angioplasty With or Without Stenting for Intracranial Artery Stenosis
Graeme J. Hankey, MD, FRCP, Section Editor:;
Salvador Cruz-Flores, MD
Alan L. Diamond, DO
From the Department of Neurology (S.C.-F.), Souers Stroke Institute, St. Louis University School of Medicine, St. Louis, Mo, and the Colorado Neurologic Institute (A.L.D.), Englewood, Colo.
Correspondence to Salvador Cruz-Flores, MD, Department of Neurology, St. Louis University Hospital, 3635 Vista Ave, St. Louis, MO. E-mail cruzfls@slu.edu
Key Words: angioplasty intracranial artery stenosis stent placement
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
Intracranial artery stenosis causes 10% of all ischemic strokes.
The annual rate of recurrent vascular ischemic events is very
high (20%).
1,2 Angioplasty with or without stent placement is
feasible; however, its safety and efficacy have not been systematically
studied.
 |
Objectives
|
|---|
We sought to determine the efficacy and safety of angioplasty
combined with best medical treatment compared with best medical
treatment alone for preventing recurrent ischemic strokes, death,
and vascular events in patients with ischemic stroke or transient
ischemic attack resulting from intracranial artery stenosis.
 |
Search Strategy
|
|---|
We searched the Cochrane Stroke Group Trials Register (last
searched March 2006), the Cochrane Central Register of Controlled
Trials (CENTRAL; The Cochrane Library Issue 1, 2006), MEDLINE
(1966 to March 2006), EMBASE (1980 to February 2006), and Science
Citation Index (1945 to March 2006). We searched reference lists
of relevant articles and contacted authors and experts in the
field.
 |
Selection Criteria
|
|---|
Randomized or otherwise-controlled studies comparing best medical
care plus angioplasty of the intracranial cerebral arteries,
with or without stent placement, with best medical care alone
were included. Studies were included only if data for clinically
significant end points such as recurrent ischemic stroke, hemorrhagic
stroke, and death were available.
 |
Data Collection and Analysis
|
|---|
Two review authors selected trials for inclusion, independently
assessed trial quality, and extracted the data. Calculation
of relative treatment effects with subgroup analysis was done
when possible.
 |
Main Results
|
|---|
No randomized controlled trials were found. There were 79 articles
of interest, consisting of open-label series with 3 or more
cases. The overall perioperative rate of stroke was 7.9% (95%
CI, 5.5%
. . . [Full Text of this Article]